← FDA DRUG APPROVALS

FDA ANDA · ANDA074968

ETOPOSIDE

Sponsor: WATSON LABS INC

APPLICATION
ANDA074968
TYPE
ANDA
ORIGINAL APPROVAL
1998-01-09
LATEST ACTION
2000-12-08
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ETOPOSIDEDiscontinued
ETOPOSIDE 20MG/ML · INJECTABLE · INJECTION

Approval history

2000-12-08Manufacturing (CMC) · Supplement 4AP
1999-09-28Manufacturing (CMC) · Supplement 3AP
1998-08-31Labeling · Supplement 1AP
1998-01-09OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →